论文部分内容阅读
通过溶解血栓来治疗急性心肌梗塞是70年代后期开始采用的一项治疗措施。心肌梗塞的发病主要是心肌动脉内血栓引起的,可以通过用药来消除动脉内的血栓,使冠状动脉血流畅通而能再灌注,以增加缺血心肌氧的供应。此法可以挽救濒死心肌,从而缩小梗塞范围,减少急性心肌梗塞的并发症。此类药物称为溶栓剂。 常用的溶栓剂是链激酶和尿激酶。链激酶静脉注
The treatment of acute myocardial infarction by thrombolysis is a treatment that was started in the late 1970s. The incidence of myocardial infarction is mainly caused by myocardial thrombosis, can be used to eliminate the thrombus in the artery, the coronary blood flow and reperfusion, to increase the supply of ischemic myocardial oxygen. This method can save the dying myocardium, thereby reducing the infarct size and reduce the complications of acute myocardial infarction. Such drugs are called thrombolytic agents. Commonly used thrombolytic agents are streptokinase and urokinase. Streptokinase intravenous injection